Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-12-01T04:39:02.921Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of repetitive transcranial magnetic stimulation in an adolescent with autism spectrum disorder and comorbid major depression disorder with anxiety symptoms: A case study

Published online by Cambridge University Press:  13 August 2021

M. Nystazaki ,
S. Kalimeris ,
A. Tsakiri ,
E. Tsalamanios  and
P. Gkikas
M. Nystazaki*
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
S. Kalimeris
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
A. Tsakiri
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
E. Tsalamanios
Affiliation:
Child And Adolescent Psychiatric Clinic, Asklipieio General Hospital of Athens, Athens, Greece
P. Gkikas
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Psychiatric comorbidities, including depressive and anxiety disorders, are common in individuals with autism spectrum disorder (ASD). Use of conventional therapies for treating depression and anxiety are of limited efficacy in individuals with ASD making treatment a challenging field. Repetitive Transcranial Magnetic Stimulation (rTMS) is a safe and efficacious technique in major depressive disorder, and a similar approach could yield therapeutic benefits in ASD.

Objectives

The aim of this case study is to present the effectiveness of rTMS in a 17 year old patient diagnosed with ASD and comorbid major depression disorder with anxiety symptoms.

Methods

This is a case study of a male adolescent aged 17, diagnosed with ASD and comorbid major depression disorder with anxiety symptoms, suicidal ideation and aggressive behavior. The protocol applied was 4 weeks of daily rTMS sessions. This involved rTMS to the left dorsomedial prefrontal cortex (10 Hz, 3.000 pulses/120% motor threshold) to treat depressive symptoms and to the right (50Hz, 600 pulses/ 120%motor threshold) to treat anxiety symptoms. Assessments were conducted using the BDI, PHQ-9 and GAD-7 scales at baseline and one month follow up. Suicidal ideation and aggressive behavior were assessed by a clinician at same intervals.

Results

Patient showed overall improvement in scores both in depression and anxiety scales. Suicidal Ideation and aggressive behavior showed significant reduction. No side effects were recorded during therapy.

Conclusions

Our findings suggest that the use of rTMS therapy in adolescents in the autistic spectrum and comorbid major depression disorder and anxiety symptoms is an efficacious and safe therapeutic treatment option.

Keywords

r-TMSmajor depression disorderautism spectrum disorder
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S227
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.